Biomarin Pharmaceutical Inc (BMRN)
91.22
-0.82
(-0.89%)
USD |
NASDAQ |
Apr 24, 16:00
87.90
-3.32
(-3.64%)
After-Hours: 20:00
Biomarin Pharmaceutical Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 50.00M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -712.94M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -888.26M |
| December 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -117.46M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.055M |
| June 30, 2012 | -235.44M |
| March 31, 2012 | |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 11.58M |
| June 30, 2011 | -8.445M |
| March 31, 2011 | -3.133M |
| December 31, 2010 | 19.89M |
| September 30, 2010 | -6.722M |
| June 30, 2010 | -13.17M |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
50.00M
Maximum
Jun 2020
8.333M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
| Eli Lilly and Co | 0.00 |
| Merck & Co Inc | 393.00M |
| Pfizer Inc | 0.00 |
| Bristol-Myers Squibb Co | 0.00 |
| Moderna Inc | 0.00 |